Yiping
Shi
,
Paul C. J.
Kamer§
and
David J.
Cole-Hamilton
*
EaStChem, School of Chemistry, University of St. Andrews, Fife, KY16 9ST, Scotland, UK. E-mail: djc@st-and.ac.uk
First published on 13th February 2019
Cardanol from cashew nut shell liquid extracted from cashew nut shells was successfully converted into various useful pharmaceutical drugs, such as norfenefrine, rac-phenylephrine, etilefrine and fenoprofene. 3-Vinylphenol, the key intermediate for the synthesis of these drugs, was synthesised from cardanol by ethenolysis to 3-non-8-enylphenol followed by isomerising ethenolysis. The metathesis reaction worked very well using DCM, but the greener solvent, 2-methyl tetrahydrofuran, also gave very similar results. Hydroxyamination of 3-vinylphenol with an iron porphyrin catalyst afforded norfenefrine in over 70% yield. Methylation and ethylation of norfenefrine afforded rac-phenylephrine and etilefrine respectively. A sequence of C–O coupling, isomerising metathesis and selective methoxycarbonylation afforded fenoprofene in good yield. A comparison of the routes described in this paper with some standard literature syntheses of 3-vinylphenol and of the drug molecules shows significant environmental advantages in terms of precursors, yields, number of steps, conditions and the use of catalysts. The Atom Economy of our processes is generally similar or significantly superior to those of the literature processes mainly because the side products produced during synthesis of 3-vinylphenol (1-octeme, 1,4-cyclohexadiene and propene) are easily separable and of commercial value, especially as they are bio-derived. The E Factor for the production of 2-vinylphenol by our process is also very low compared with those of previously reported syntheses.
CNSL contains a mixture of products including anacardic acid, 1, cardanol, 2, cardol, 3, and 2-methylcardol, 4, which contain different functional groups, the aromatic ring, the hydroxyl group, the carboxylic acid and the double bonds in the alkyl chain (Fig. 1). For this reason, cashew nut shell liquid has versatile applications, and it can be used for a wide range of chemical modifications to produce useful monomer precursors. CNSL derived material can be used as chemical intermediates, additives,4,5 stabilizers,6 lubricants,7 diesel engine fuel alternatives,8 anti-oxidants,9 anticorrosive paints, sodium cardanol sulfate detergent,10 coating, brake linings11 and resins.12 Although there is a large number of applications of cashew nut shell liquid (CNSL) and its components, anacardic acid and cardanol, there are very few examples of the transformation of cashew nut shell liquid and its components into small value-added molecules. The examples predominantly focused on the metathesis of the double bonds in anacardic acid and cardanols using either homogeneous or heterogeneous catalysis (the latter with Ru catalysts supported on mesoporous molecular sieve SBA-15).13
Metathesis reactions of anacardic acid and cardanol for the synthesis of fine chemicals and new hybrid functional materials have been reviewed.14 Cardanol porphyrins, cardanol phthalocyanines and cardanol fullerenes can all be produced by metathesis of cardanol derivatives.14 These interesting studies enabled the synthesis of challenging molecules. However, it would be more interesting to synthesise products with practical use. It has previously been reported in our group that the tsetse fly attractants, 3-ethyl phenol and 3-propyl phenol can both be produced selectively in good yields (>80%) from cardanol.15
We have also used homogeneous metathesis,16–18 isomerising metathesis,15 methoxycarbonylation18 and isomerisation17,19 to make higher added value chemicals such as 3-nonylphenol,16,17 1-octene,16,17 1,3-cyclohexadiene,16,17 which allows ethenolysis using simple first generation metathesis catalysts,16,20 potential monomers containing hydroxy and carboxyl groups,18 fused bicyclic compounds19 and large ring macrocyles.18 To the best of our knowledge, the only report of converting CNSL, anacardic acid or cardanol into pharmaceutical drugs is the synthesis of ginkgolic acid, a tyrosinase inhibitor, from anacardic acid, which appeared while this manuscript was under review.21 although we have reported the synthesis of a substituted isochromen-1-one which has some structural similarities to massoia lactone from anarcardic acid.19 Pharmaceutical drugs are mainly synthesised from fossil fuels by stoichiometric reactions, and in some cases toxic reagents such as cyanide are involved, which renders the synthesis environmentally unfriendly. Our target was to synthesise pharmaceutical drugs from renewable feedstocks which do not compete with food. An inedible by-product from food processing, in this case cashew nut shell liquid, is therefore a very good starting material. The aromatic and olefin functional groups make cardanol suitable for this purpose. After searching through the drug database, five drugs (fenoprofen, 5, norfenefrine, 6, phenylephrine, 7, etilefrine, 8, and metaraminol, 9) were found to be of potential interest. The importance and the current synthesis of these drugs will be discussed in detail later. Their general structures, containing a meta-hydroxyl group, are similar to the ones in cardanol, 2, or anacardic acid, 1, from CNSL (highlighted in red, Scheme 1). Only a few steps of modification are needed to convert food by-products into high value and important medicines, which will be discussed in detail later.
Scheme 2 Synthesis of 3-vinyl phenol by isomerising metathesis using a palladium dimer (isomerisation) and M1 (metathesis) catalyst. |
Entry | Substrate | Catalyst | Yield (%) |
---|---|---|---|
a Reagents and conditions: Substrate (3 mmol), catalyst (0.3 mol%), anhydrous DCM (7.5 mL), ethene (10 bar), 24 h, r.t. b 2-Methyl THF (7.5 mL) instead of DCM. | |||
1 | Cardanol | HG1 | 96 |
2 | Cardanol | G1 | 85 |
3 | Cardanol | HG2 | 11 |
4b | Cardanol | HG1 | 93 |
5 | Anacardic acid | HG2 | <1 |
6 | Anacardic acid | HG1 | 1 |
The synthesis of 3-vinylphenol, 10, could also, in principle, be carried out by a two-step synthesis: isomerisation of cardanol to the benzylic cardanol followed by ethenolysis. Previous studies in our group showed that the [Pd2(dba)3]/DTBPMB/MSA system, which is active for the isomerising methoxycarbonylation of methyl oleate,22 and is a good isomerisation catalyst in the absence of CO, is effective for isomerising cardanol, although the yield of benzylic alkene was only 40%. This is the thermodynamic maximum. Although the styrene will be the most thermodynamically favoured isomer, the conjugation energy is insufficient to overcome the entropic advantage of having the double bond in other positions in the chain completely. Therefore, the cardanol was shortened by ethenolysis to produce 3-(non-8-enyl)phenol, 11, with the method previously mentioned (96% yield, Table 1, entry 1). 3-(Non-8-enyl)phenol, 11, was isomerized with [Pd2(dba)3]/DTBPMB/MSA in toluene at 80 °C, after 64 hours, the benzylic product, 3-(non-1-en-1-yl)phenol, 17, was obtained in 68% selectivity over all the other isomers (Table 2, entry 1). Heating at 80 °C for 96 hours led to 71% selectivity of 17 (Table 2, entry 2). Isomerisation of 3-(non-8-enyl)phenol with Pd catalyst can also be carried out in other solvents. Very similar results were obtained in DCM, THF or in a greener solvent, 2-MeTHF (Table 2, entries 3–8). [Rh(acac)(CO)2] together with DTBPMB ligand is known to be effective in isomerising hydroformylation of cardanol,23 therefore, it was interesting to find out whether [Rh(acac)(CO)2]/DTBPMB is effective in the isomerization reaction in the absence of CO/H2 gas. However, no benzylic alkene was observed after 64 hours, and only 28% of the terminal alkene was converted to other internal alkenes (Table 2, entry 9).
Entry | Cat prec. | solvent | T (°C) | t (h) | Sel. (benzylic alkene/others)b (%) |
---|---|---|---|---|---|
a Reagents and conditions: Substrate (50 mg, 0.2 mmol, 1 equiv.), catalyst (5 mol%) DTBPMB (0.5 equiv.), MSA (0.7 equiv.), solvent (1 mL). b Selectivity calculated by quantitative 1H NMR. | |||||
1 | [Pd2(dba)3] | Toluene | 80 | 64 | 68 |
2 | [Pd2(dba)3] | Toluene | 80 | 96 | 71 |
3 | [Pd2(dba)3] | DCM | 40 | 64 | 68 |
4 | [Pd2(dba)3] | DCM | 40 | 96 | 70 |
5 | [Pd2(dba)3] | THF | 70 | 64 | 62 |
6 | [Pd2(dba)3] | THF | 70 | 96 | 62 |
7 | [Pd2(dba)3] | 2-MeTHF | 80 | 64 | 63 |
8 | [Pd2(dba)3] | 2-MeTHF | 80 | 96 | 63 |
9 | [Rh(acac)(CO)2] | Toluene | 80 | 64 | 0 |
After isomerization of 3-(non-8-enyl)phenol, 11, the metathesis reaction was then carried out on the crude product from the isomerisation step (71% of 17, Table 2, entry 2). The crude product was metathesized using M1 catalyst, 15, and 3-vinylphenol, 10, was obtained in 65% yield by GC-FID together with alkenyl phenols with longer chain lengths (Scheme 3).
As presented in Scheme 1, 3-vinylphenol, 10, which was successfully obtained from cardanol by ethenolysis followed by isomerising metathesis, could possibly be used as an intermediate for the synthesis of norfenefrine, 6, by a hydroxyamination reaction on the double bond. Morandi reported a reaction of this kind which converts 1-methoxy-3-vinylbenzene, 18, to 2-amino-1-(3-methoxyphenyl)ethan-1-ol, 19, in 70% yield using an iron catalyst and O-pivaloylhydroxylammonium triflate (Scheme 4, Reaction A).24 We employed a similar method using 3-vinylphenol, 10, as substrate, and the desired norfenefrine, 6, which is also known as 3-(2-amino-1-hydroxyethyl)phenol, was obtained in 71% isolated yield (Scheme 4, Reaction B).
Scheme 4 Hydroxyamination of styrene type substrate. (A) Literature hydroxyamination of 1-methoxy-3-vinylbenzene, 18.24 (B) Experimental synthesis of norfenefrine, 6, from 3-vinylphenol, 10. |
Scheme 5 Synthesis of metaraminol, 9, and related literature results.24 |
When reacting norfenefrine, 6, with methyl iodide in the presence of a base, a rather complicated mixture of products was obtained, which might be because of methylation on alcohol, mono- and dimethylated products, and selective methylation was not achieved by this method (Table 3, entries 1 and 2). It has been reported that 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) is a good solvent for the selective alkylation of amines, producing a high proportion of mono-alkylated products over di-alkylated products.22 Methylation of norfenefrine with methyl iodide in HFIP in the absence of base gave very poor conversion, and low yield of the desired phenylephrine (Table 3, entry 3). By changing the methylation agent from methyl iodide to methyl triflate, much higher conversion was observed, and the desired phenylephrine, 7, was obtained in 79% yield (Table 3, entry 4).
Entry | MX | Solvent | T (°C) | t (h) | Conv.b (%) | Yieldb (%) |
---|---|---|---|---|---|---|
a Conditions: Norfenefrine (1 mmol), MeX (1.5 mmol), HFIP (1 mL). b Conversions and yields were calculated by 1H NMR spectroscopy. c KOH (2 equiv.). | ||||||
1c | MeI | Acetone | 60 | 2 | 100 | n.d. |
2c | MeI | DMSO | 100 | 16 | 100 | n.d |
3 | MeI | HFIP | 25 | 24 | 4 | 2 |
4 | MeOTf | HFIP | 25 | 1 | 84 | 79 |
Reductive amination was used for the selective alkylation of nitrogen over the oxygen. When reacting norfenefrine, 6, with acetaldehyde in the presence of sodium borohydride, both the desired etilefrine, 8, and the side diethylated product 23 were obtained, and they were easily separated by flash column chromatography. The expected etilefrine, 8, was obtained in 54% yield, and the diethylated product was obtained in 35% yield (Scheme 6).
Due to the success of the methylation procedure for the selective mono-methylation of norfenefrine, we employed these conditions in the synthesis of etilefrine using ethyl triflate as the ethyl source. The ethylation of norfenefrine with ethyl triflate in HFIP led to a higher yield of the desired etilefrine (79%) compared to the reductive amination, together with 17% of the diethylated product after 1 hour at room temperature (Scheme 7).
A few synthetic pathways have been tested (ESI, section S1‡). The best reaction pathway is to convert cardanol to the O-Ph cardanol, 24, firstly, which could avoid the complexity of the C–O coupling with unstable intermediates (e.g. styrene intermediate 10 in Scheme S1‡).
Cardanol, 3, was therefore reacted with bromobenzene first in the presence of anhydrous potassium tert-butoxide under literature conditions for the C–O coupling of the phenol (Step A, Scheme 8).29 Only about 30% of cardanol was converted to the O-Ph product, 24, at 45 °C. Increasing the temperature increased the conversion, and at 100 °C, the starting material was fully converted. Preparative scale gave similar results, and the O-Ph cardanol, 24, was successfully synthesised in 82% yield.
After obtaining O-Ph cardanol, 24, 1-phenoxy-3-vinylbenzene, 25, can be synthesized in two steps (Step B and C in Scheme 8). Firstly, the O-Ph cardanol, 24, was metathesized to the corresponding 1-(non-8-en-1-yl)-3-phenoxybenzene, 26, using HG1 catalyst in high yield (97%) with 1-octene as the side product. 1-(Non-8-en-1-yl)-3-phenoxybenzene, 26, was then converted to 1-phenoxy-3-vinylbenzene, 25, by the isomerising metathesis reaction with palladium dimer and M1 catalysis, as discussed earlier for the synthesis of 3-vinylphenol. A one-pot isomerising metathesis of 1-(non-8-en-1-yl)-3-phenoxybenzene, 26, first afforded a mixture of 1-phenoxy-3-vinylbenzene, 25, and 1-phenoxy-3-(prop-1-en-1-yl)benzene, 27. The crude mixture was filtered through a plug of silica, and metathesized again with M1 catalyst. The desired 1-phenoxy-3-vinylbenzene, 25, was successfully obtained in 80% yield (Scheme 9).
The next step is the synthesis of the branched ester 28 (Step D, Scheme 8). Branch selective methoxycarbonylation with Pd/DTBPMB system in the presence of racemic BINOL-phosphoric acid (rac-BNPA) afforded the desired product 28 in 82% yield together with 12% of the linear product, methyl 3-(3-phenoxyphenyl)propanoate, 29 (Scheme 10). Hydrolysis of 28 in 1,4-dioxane afforded fenoprofen, 5, in 91% yield. The hydrolysis of 28 can also be carried out in DMSO, which afford the desired fenoprofen, 5, in 92% yield. However, the hydrolysis reaction in 2-MeTHF did not give the desired product at all. With this method, biomass is successfully converted to fenoprofen drug in good yield (47.5% overall yield from cardanol, 2).
Enantioselective synthesis of the branched ester 28, from 1-phenoxy-3-vinylbenzene, 25, was also performed using a catalyst developed by Clarke,3030 (Scheme 11). After 17 h, 44% conversion was observed, with 69% branched to linear selectivity and 88% ee.
Scheme 11 Enantioselective methoxycarbonylation of 1-phenoxy-3-vinylbenzene. Reagents: 1-Phenoxy-3-vinylbenzene (0.55 mmol), LiCl (2 mol%), para-toluenesulfonic acid monohydrate (2 equiv.), 30 (1 mol%), MeOH (0.75 mL), CO (30 bar), 40 °C, 17 h.30 |
The main platform chemical for this study is 3-vinylphenyl, which we have synthesised from cardanol in 75% isolated yield after two steps. 3-Vinylphenol has been made in one step by pyrolysis of cardanol31,32 or from fossil fuel derived cyclohexanone.33 We note that the first step of our synthesis, ethenolysis of cardanol produces products as shown in Fig. 2.
Fig. 2 Products from the ethenolysis of each component of cardanol. The percentage figures on the right refer to the amount of each component in the batch used in this study. |
It is clear from analysis of Table 4 that our route is superior to pyrolysis because of the low temperatures used, the high yield and the side products. 1-Octene (from ethenolysis of cardanol containing 1 double bond is a valuable chemical used as a co-monomer for polyethylene and is required on 500000 tonne per year in the US alone at a value of $1–2000 per tonne.34,35 1,4-Cyclohexadiene (self-metathesis of cardanol containing 3 double bonds; note that this does not require ethene) is a useful organic synthon and hydrogen donor or acceptor36 and we have shown that it can allow ethenolysis of a number of alkenes including methyl oleate to proceed cleanly using cheap first-generation ruthenium-based metathesis catalysts.16,37 Indeed, it is essential for the clean ethenoylsis of cardanol in the first step of the synthesis of 3-vinylphenol discussed here. Both 1-octene and cyclohexanone can be separated easily from one another and from 3-(non-8-enyl)phenol by distillation. The second step of the synthesis of 3-vinylphenol produces propene (>94%)15 as the by-product. This is also a valuable commodity chemical (∼100000 tonnes per year) used for making polymers and plasticisers and in the cumarin process for the manufacture of phenol.38 The price of propene39 is similar to that of ethene40 per mol, so making it as a side product in this way is an attractive proposition.
Metathesis of cardanol | Pyrolysis of cardanol31,32 | From 3-vinylcyclohex-2-enone33 | ||
---|---|---|---|---|
Number of steps | 2 | 1 | 1 | |
Step 1 | Step 2 | 6 from benzene | ||
Other reagents | C2H4 | C2H4 | None | DMSO |
Temperature /°C | 25 | 40–80 | 540–600 | 100 |
Isolated yield/% | 96 | 70 | 12–15 | 45% (final step) |
Side products | 1-Octene, 1,4-cyclohexadiene | Propene | 3-Ethylphenol, 3-methylphenol, phenol, alkenes and alkanes (C2–4 and higher), high boiling residue | Unknown |
Small amount of volatile hydrocarbons from cardanol with 2 double bonds. | ||||
Atom economy42,43 | 65 | 47 | ||
Overall atom economy | 31 | 40 | 59.4 | |
Atom economy (all usable products) | 92 | 100 | ||
Over all atom economy (all usable products | 92 | 40 | 59.4 | |
E Factor44,45/kg (waste) kg (products)−1 | 0.09 | 0.1 | 76 |
As the demand for bio derived polymers rises, bio-1-octene and bio-propene will also be essential. The first step of our process produces 1-octene with 87.5% of the C derived from bioresources. If the ethenolysis were carried out using bio-ethene, from bioethanol, the 1-ocetene would be 100% bio-derived. Similarly, if bio-ethene were used for the isomerising metathesis, 100% bio-propene would be the by-product.
On the basis of atom economy, the synthesis of 3-vinylphenol from 3-vinylcyclohex-2-enone33 looks attractive. However, the oxidant is dimethylsulphoxide, which gives no useful side products and the yield is only 45%. For a direct comparison, we need to look at the synthesis from basic building blocks. 3-Vinylcyclohex-2-enone is derived from benzene, a non renewable resource in six steps via cumarin, cumarin peroxide, phenol, cyclohexan-2-one (Birch reduction) and finally 3-vinyl cyclohex-2-enone.41 Many of these steps are atom inefficient and or involve stoichiometric metal reagents.
Thus, on the basis of simplicity, mild conditions (important because 3-vinylphenol is unstable), yield, renewable resources that are of low value and not used in food and the value of the side products, the synthesis of 3-vinylphenol from cardanol seems to be very much more attractive than other available syntheses.
Although we have demonstrated significant advantages of the routes to certain pharmaceuticals described in this paper over conventional synthetic processes, we acknowledge that the synthesis of drugs and their precursors is tightly controlled by the United Nations Convention59 against illicit drugs and psychotropic substances, 1988 and EU60 legislation and that the high purity required of the final products is also enforced under the International Convention on Harmonisation (ICH) Guidelines.61 Further work on the process engineering by qualified API or drug manufacturers will be required before these routes from cardanol can be fully implemented.
Footnotes |
† Dedicated to Ernesto Carmona, and outstanding chemist and great friend, on the occasion of his 70th birthday. |
‡ Electronic supplementary information (ESI) available. See DOI: 10.1039/c8gc03823f |
§ Current address: Bioinspired Homo- & Heterogeneous catalysis, Leibniz Institute for Catalysis, Albert-Einstein-Straβe 29 a, 18059 Rostock, Germany. |
This journal is © The Royal Society of Chemistry 2019 |